CRISPR gene-editing technologies could pave a key pathway to preventing and treating disease, but applying them requires a full understanding and thoughtful consideration of their mechanisms.
Longtime division director Dr. Judith Fradkin retires
The former director of the Division of Diabetes, Endocrinology, and Metabolic Diseases served nearly 40 years at NIDDK and oversaw ambitious clinical trials to advance the prevention and treatment of diabetes.